Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery

被引：30

作者：

Danilos, J

Goral, A

Paluszkiewicz, P

Przesmycki, K

Kotarski, J

机构：

[1] Med Univ, Dept Gynecol 1, PL-20081 Lublin, Poland

[2] Med Univ, Dept Anesthesiol & Intens Therapy 2, PL-20081 Lublin, Poland

[3] Med Univ, Dept Traumat Surg, PL-20081 Lublin, Poland

来源：

OBSTETRICS AND GYNECOLOGY | 2003年 / 101卷 / 06期

关键词：

D O I：

10.1016/S0029-7844(03)00349-1

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

BACKGROUND: Postoperative bleeding may be complicated by failure to identify the site of bleeding, multiple bleeding points, and persistent hemorrhage despite surgical intervention. CASE: Activated recombinant factor VII was used successfully in a patient with life-threatening postsurgical bleeding after resection of two large extraperitoneal pelvic sarcomas. CONCLUSION: In severe hemorrhage, hemostasis can be achieved with activated recombinant factor VII (C) 2003 by The American College of Obstetricians and Gynecologists.

引用

页码：1172 / 1173

页数：2

共 7 条

[1] Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery [J].